Anticardiolipin antibodies as a risk factor of atherosclerosis in intermittent claudication

Angiology

Volumn 55, Issue 4, 2004, Pages 357-359

  Pereira De Godoy, José Maria ^a,b   Batigália, Fernando ^a   Pereira De Godoy, Maria Regina ^a   Brandão, Antonio Carlos ^a   Souza, Dorotéia R S ^a  

^a Sao Jose do Rio Preto University School of Medicine   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; AGED; ANTIBODY TITER; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; MALE; RISK FACTOR;

AGED; AGED, 80 AND OVER; ANTIBODIES, ANTICARDIOLIPIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; RISK FACTORS;

EID: 3142668374     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970405500402     Document Type: Article

References (18)

1. Hugles GVR, Harris EN, Gharavi AR: The anticardiolipin syndrome. J Rheumatol 1996;13:486-489.
2. Sammaritano LR, Gharavi AE, Lockshin MD: Antiphospholipid antibody syndrome: Immunologic and clinical aspects. Semin Arthritis Rheum 20:81-96, 1990.
3. Godoy JMP, Godoy MF, Vogelfang D: La prevalencia de los anticuerpos antifosfolipfdios en la trombosis venosa periferica. Patol Vasc 3:43-50, 1997.
4. Godoy JMP, Braile DM, Torres CAA, et al: Prevalence of anticardiolipin antibodies in peripheral arterial thrombosis. Angiology 51:473-477, 2000.
5. Evans SM, Brittenden J, Adam DJ, et al: Vascular Surgical Society of Great Britain and Ireland: Prevalence and significance of thrombophilias in patients with intermittent claudication. Br J Surg 86:702-703, 1999.
6. Gagne PJ, Vitti MJ, Fink LM, et al: Young women with advanced aortoiliac occlusive disease: New insights. Ann Vasc Surg 10:546-557, 1996.
7. George J, Shoenfeld Y, Harats D: The involvement of beta2-glycoprotein I (beta2-GP1) in human and murine atherosclerosis. J Autoimmun 13:57-60, 1999.
8. Vaarala O: Antiphospholipid antibodies and myocardial infarction. Lupus 7s:132-134, 1998.
9. Romero FI, Khasmatha MA, Hugles GR: Lipoprotein (a) oxidation and autoantibodies: A new path in atherosclerosis. Lupus 9:206-209, 2000.
10. George J, Afek A, Gilburd B, et al: Autoimmunity in atherosclerosis: Lesson from experimental models. Lupus 9:223-227, 2000.
11. Koike T: Antiphospholipid antibodies in arterial thrombosis. Ann Med 32:27-31, 2000.
12. George J, Harats D, Gilburd B, et al: Immonolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerosis plaques: Potential implications for lesion progression. Circulation 99:2227-2230, 1999.
13. Matsura E, Kobayashi K, Yassuda T, et al: Antiphospholipid antibodies and atherosclerosis. Lupus 7s: 135-139, 1998.
14. Romero FI, Atsumi T, Tinahones FJ, et al: Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome. Arthritis Rheum 42:2606-2611, 1999.
15. Lam EY, Taylor LM, Landry GJ, et al: Relationship between antiphospholipid antibodies and progression of lower extremity arterial occlusive disease after lower extremity bypass operations. J Vasc Surg 33:976-982, 2001.
16. Godoy JMP, Lúpino PL, Souza DRS, et al: Prevalência de Anticorpos Anticardiolipina em doadores voluntários de banco de sangue. Bol Soc Hematol Hemat 20:65-68, 1998.
17. Erkkila AT, Narvanen O, Letho S, et al: Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 20:204-209, 2000.
18. Hunt BJ: The endothelium in atherosclerosis. Lupus 9:189-193, 2000.